Work for PhaseRx, Inc.?

Claim Your Profile

PhaseRx, Inc. Logo Image

PhaseRx, Inc.

PhaseRx, Inc. Banner Image

PhaseRx, Inc. has reached its limit for report views.

Please check back to see if PhaseRx, Inc. has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

About PhaseRx, Inc.

11-50 Employees
Based in Seattle, Washington

PhaseRx is a biopharmaceutical company dedicated to developing mRNA products for the treatment of children with inherited enzyme deficiencies in the liver using intracellular enzyme replacement therapy (i-ERT). PhaseRx's initial product development focus is on urea cycle disorders, a group of rare genetic diseases that generally present before the age of twelve and are characterized by the body's inability to remove ammonia from the blood with potentially devastating consequences for patients.

Ticker:
PZRX
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol